Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

DOI Web Site Web Site 1 Citations

Journal

  • Lung Cancer

    Lung Cancer 75 (1), 82-88, 2012-01

    Elsevier BV

Citations (1)*help

See more

Report a problem

Back to top